Company Cardio Diagnostics Holdings, Inc.

Equities

CDIO

US14159C2026

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 10:14:18 2026-02-18 EST			5-day change	1st Jan Change
1.320 ^USD	+10.92%		0.00%	-51.29%

01-07	Cardio Diagnostics Holdings, Inc, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD Test in India	CI
01-07	Top Premarket Gainers	MT

Business description: Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Number of employees: 14

Sales by Activity: Cardio Diagnostics Holdings, Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Product Testing	-	901	950	17.06K	34.89K

See all business segments

Geographical breakdown of sales: Cardio Diagnostics Holdings, Inc.

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
United States	-	901	950	17.06K	34.89K

See all geographic segments

Executive Committee: Cardio Diagnostics Holdings, Inc.

Manager	Title	Age	Since
Meeshanthini Dogan CEO	Chief Executive Officer	37	2022-10-24
Elisa Luqman DFI	Director of Finance/CFO	61	2022-10-24
Timur Dogan CTO	Chief Tech/Sci/R&D Officer	38	2022-10-24
Robert Philibert CTO	Chief Tech/Sci/R&D Officer	65	2022-10-24
Gene Mannheimer IRC	Investor Relations Contact	-	-

See CARDIO DIAGNOSTICS HOLDINGS, INC. governance

Composition of the Board of Directors: Cardio Diagnostics Holdings, Inc.

Director	Title	Age	Since
Warren Hosseinion CHM	Chairman	54	2022-10-24
Paul Burton BRD	Director/Board Member	-	2023-12-20
Meeshanthini Dogan BRD	Director/Board Member	37	2022-10-24
Robert Philibert BRD	Director/Board Member	65	2022-10-24
James Intrater BRD	Director/Board Member	62	2022-10-24
Wendy Betts BRD	Director/Board Member	54	2024-11-14
Peter Fung BRD	Director/Board Member	-	2024-11-14

Composition of the Board of Directors

Shareholders: Cardio Diagnostics Holdings, Inc.

Name	Equities	%	Valuation
Robert Philibert 3.074 %	56,130	3.074 %	84 756 $
Meeshanthini Dogan 3.022 %	55,181	3.022 %	83 323 $
DRW Securities LLC 2.216 %	40,463	2.216 %	61 099 $
BlackRock Institutional Trust Co. NA 1.948 %	35,567	1.948 %	53 706 $
Vanguard Fiduciary Trust Co. 1.321 %	24,124	1.321 %	36 427 $

Name	Equities	%	Valuation
Saba Capital Management LP -	199,839	-	3 397 $
Clear Street Group, Inc. -	82,442	-	1 402 $
Context Capital Management LLC -	81,500	-	1 386 $
D.E. Shaw & Co., Inc. -	74,822	-	1 272 $
ATW SPAC Management LLC -	60,540	-	1 029 $

List of CARDIO DIAGNOSTICS HOLDINGS, INC. shareholders

Company details: Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.

311 West Superior Street

60654, Chicago

http://www.cdio.ai

address Cardio Diagnostics Holdings, Inc.(CDIO)

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
CARDIO DIAGNOSTICS HOLDINGS, INC.	+10.92%	0.00%	-92.77%	-96.04%	2.17M
ARGENX SE	+0.25%	+1.60%	+16.00%	+104.25%	51.41B
WUXI APPTEC CO., LTD.	-2.85%	+0.55%	+63.53%	+19.60%	44.43B
INSMED INCORPORATED	+1.58%	+2.84%	+87.61%	+653.03%	32.1B
BIONTECH SE	+0.66%	-1.52%	-12.24%	-21.68%	26.85B
WUXI BIOLOGICS (CAYMAN) INC.	+1.25%	+1.20%	+72.71%	-28.51%	21.44B
GENMAB A/S	-6.08%	-2.87%	+18.67%	-33.98%	19.05B
AKESO, INC.	-0.09%	-0.47%	+77.55%	+148.70%	12.4B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.43%	-5.63%	+127.45%	-	12.31B
SUMMIT THERAPEUTICS INC.	+1.95%	+4.85%	-24.15%	+604.41%	12.09B
Average	+0.63%	+0.12%	+33.44%	+149.98%	23.21B
Weighted average by Cap.	-0.55%	+1.50%	+44.30%	+157.01%